Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo
暂无分享,去创建一个
M. Detmar | J. Leroux | P. Luciani | A. Christiansen | Steven T. Proulx | A. Alitalo | Viviane Mumprecht | R. Huggenberger
[1] E. Schwarz,et al. Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. , 2011, Arthritis and rheumatism.
[2] S. Werner,et al. An important role of lymphatic vessel activation in limiting acute inflammation. , 2011, Blood.
[3] E. Kenne,et al. Imaging inflammatory plasma leakage in vivo , 2011, Thrombosis and Haemostasis.
[4] S. Yuan,et al. Regulation of Endothelial Barrier Function , 2011 .
[5] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[6] K. Alitalo,et al. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation , 2010, The Journal of experimental medicine.
[7] Michael Detmar,et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. , 2010, Cancer research.
[8] F. Curry,et al. Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. , 2010, Cardiovascular research.
[9] J. Levick,et al. Microvascular fluid exchange and the revised Starling principle. , 2010, Cardiovascular research.
[10] Arjan W. Griffioen,et al. Imaging of angiogenesis , 2010, Angiogenesis.
[11] S. K. Wyatt,et al. Molecular Imaging of the Translocator Protein (TSPO) in a Pre-Clinical Model of Breast Cancer , 2010, Molecular Imaging and Biology.
[12] M. Neeman,et al. Visualizing vascular permeability and lymphatic drainage using labeled serum albumin , 2010, Angiogenesis.
[13] D. Bates. Vascular endothelial growth factors and vascular permeability , 2010, Cardiovascular research.
[14] Eva M. Sevick-Muraca,et al. Single-Dose Intravenous Toxicity Study of IRDye 800CW in Sprague-Dawley Rats , 2010, Molecular Imaging and Biology.
[15] Virginia H. Huxley,et al. Capillary Fluid Exchange: Regulation, Functions, and Pathology , 2010 .
[16] K. Alitalo,et al. Lymphangiogenesis: Molecular Mechanisms and Future Promise , 2010, Cell.
[17] Jean M. J. Fréchet,et al. Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture , 2010 .
[18] Ralph Weissleder,et al. Near-infrared fluorescence: application to in vivo molecular imaging. , 2010, Current opinion in chemical biology.
[19] L. Ngo,et al. The FLARE™ Intraoperative Near-Infrared Fluorescence Imaging System: A First-in-Human Clinical Trial in Breast Cancer Sentinel Lymph Node Mapping , 2009, Annals of Surgical Oncology.
[20] Elisabetta Dejana,et al. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.
[21] K. Alitalo,et al. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. , 2008, The American journal of pathology.
[22] H. Dvorak,et al. Vascular permeability, vascular hyperpermeability and angiogenesis , 2008, Angiogenesis.
[23] C. Beck,et al. MRI and Quantification of Draining Lymph Node Function in Inflammatory Arthritis , 2007, Annals of the New York Academy of Sciences.
[24] H. Dvorak,et al. VEGF-A and the induction of pathological angiogenesis. , 2007, Annual review of pathology.
[25] Khaled Greish,et al. Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines , 2007, Journal of drug targeting.
[26] Seppo Yla-Herttuala,et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. , 2006, The American journal of pathology.
[27] M. Dewhirst,et al. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.
[28] Seppo Ylä-Herttuala,et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. , 2005, The Journal of clinical investigation.
[29] D. Hicklin,et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. , 2004, Blood.
[30] Michal Neeman,et al. Structural, functional, and molecular MR imaging of the microvasculature. , 2003, Annual review of biomedical engineering.
[31] Vishal Saxena,et al. Degradation kinetics of indocyanine green in aqueous solution. , 2003, Journal of pharmaceutical sciences.
[32] G. Yancopoulos,et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. , 2003, Blood.
[33] Richard B Greenwald,et al. Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.
[34] T. Veikkola,et al. Adenoviral VEGF‐C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] Michal Neeman,et al. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper‐permeability and lymphatic uptake, followed by rapid inactivation of the growth factor , 2002, NMR in biomedicine.
[36] Thomas N. Sato,et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.
[37] J. Isner,et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.
[38] R K Jain,et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.
[39] K. Alitalo,et al. A Recombinant Mutant Vascular Endothelial Growth Factor-C that Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities* , 1998, The Journal of Biological Chemistry.
[40] R. Jain,et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.
[41] P Ott,et al. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: Comparison of spectrophotometry and high‐pressure liquid chromatography for concentration analysis , 1993, Hepatology.
[42] C. S. Davidson,et al. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. , 1960, The Journal of clinical investigation.
[43] A. A. Miles,et al. Vascular reactions to histamine, histamine‐liberator and leukotaxine in the skin of guinea‐pigs , 1952, The Journal of physiology.
[44] H. Wiig,et al. Minimally invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin. , 2012, American Journal of Physiology. Heart and Circulatory Physiology.
[45] H. Gremlich,et al. Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation. , 2010, Bioconjugate chemistry.
[46] M. Detmar,et al. Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. , 2008, Methods in enzymology.
[47] Josef Machac,et al. Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.